Zacks Investment Research on MSN1d
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth StockTaking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...
SAN RAFAEL, Calif. (AP) — SAN RAFAEL, Calif. (AP) — BioMarin Pharmaceutical Inc. (BMRN) on Wednesday reported fourth-quarter profit of $124.9 million. The San Rafael, California-based company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback